Livagen 20mg

Livagen 20 mg is a high-purity lyophilized peptide research compound supplied exclusively for scientific investigation and controlled laboratory experimentation.

For research use only — not for human or veterinary use.

Product Overview

Livagen is a synthetic short-chain peptide research compound frequently investigated in controlled laboratory environments focused on peptide signalling systems, molecular communication pathways and intracellular regulatory mechanisms.

The peptide has attracted continued scientific interest due to its compact molecular structure, reproducible analytical profile and suitability for advanced peptide-focused laboratory investigations.

This preparation contains 20 mg of lyophilized Livagen supplied in a sealed research vial. Lyophilization helps preserve peptide stability during storage while allowing controlled reconstitution for laboratory applications.

Due to its clearly defined molecular characteristics and well-documented analytical profile, Livagen remains a recognised research material within peptide science and controlled in vitro experimentation.

Peptide Overview

Livagen is a synthetic short-chain peptide commonly studied in controlled laboratory settings examining peptide-mediated signalling pathways, molecular communication systems and intracellular interaction networks.

Researchers frequently utilise Livagen in experimental models investigating peptide signalling behaviour, cellular communication systems and regulatory molecular mechanisms.

The peptide’s compact molecular structure and highly reproducible analytical characteristics have contributed to its continued importance within scientific peptide research.

Its ongoing presence in peptide-focused investigations has established Livagen as a recognised compound for advanced laboratory studies involving molecular signalling and peptide interaction analysis.

Historical Background and Scientific Context

Scientific interest in synthetic regulatory peptides expanded considerably as advances in peptide synthesis and analytical chemistry enabled increasingly precise investigation of molecular signalling mechanisms.

Short-chain peptides became valuable research tools for studying intracellular communication pathways, biochemical regulation and peptide-mediated signalling systems under carefully controlled laboratory conditions.

Livagen subsequently became one of several synthetic peptides investigated in molecular biology and peptide science due to its defined structure, reproducible analytical profile and suitability for laboratory research.

Today, Livagen continues to appear within peptide research literature involving molecular signalling, peptide chemistry and controlled biochemical investigations.

Mechanistic Focus in Research

Within controlled laboratory settings, Livagen is commonly studied in relation to peptide-mediated signalling pathways and intracellular communication systems.

Research investigations frequently explore:

• Peptide signalling pathways
• Molecular interaction dynamics
• Intracellular communication systems
• Signal transduction mechanisms
• Comparative peptide investigations
• Molecular pathway analysis
• Regulatory signalling mechanisms

These experimental models allow researchers to investigate complex molecular communication processes and peptide-mediated biological systems under highly controlled laboratory conditions.

Analytical Verification (COA)

Each batch of Livagen supplied by Grail Formula undergoes independent third-party laboratory verification to confirm peptide identity, assay content, purity and microbiological safety.

Analytical testing for this batch was performed by Liquilabs s.r.o. (Czechia) using validated chromatographic, spectrometric, microbiological and mass spectrometry techniques.

Batch: GF-LIVAG20-B241

• Assay Content: 19.1 mg
• Purity: 99.8 percent
• Identification by FTIR Spectrum: 998
• Identification by Retention Time: 0.985
• Molecular Ion Mass Identification: 461 Da
• Bacterial Endotoxins: below 0.001 EU/mg
• Total Aerobic Microbial Count: 0 CFU/g
• Total Yeast and Mold Count: 0 CFU/g

Independent elemental impurity screening confirmed no detectable arsenic, cadmium, cobalt, lead, mercury, nickel or vanadium, with all measured values below the laboratory detection limit.

Microbiological screening confirmed no detectable aerobic microorganisms, yeasts or moulds, supporting laboratory-grade quality standards.

These analytical procedures provide confirmation of identity, purity, traceability and batch consistency for scientific laboratory applications.

Research Applications

In controlled laboratory environments, Livagen may be utilised in experimental models designed to investigate peptide signalling systems, intracellular communication pathways and molecular regulatory mechanisms.

Examples of research applications include:

• Peptide signalling investigations
• Intracellular communication studies
• Molecular pathway analysis
• Comparative peptide research
• Signal transduction investigations
• Laboratory interaction studies
• Controlled in vitro peptide experiments

These applications are intended exclusively for scientific and laboratory investigation.

Grail Formula Quality

Every Grail Formula research compound is supported by extensive independent analytical verification and complete batch traceability.

Each batch undergoes testing for:

• Peptide identity confirmation
• Assay content verification
• Purity assessment
• Molecular ion mass verification
• Endotoxin analysis
• Microbial contamination screening
• Heavy metal screening
• Complete batch traceability

Independent laboratory testing helps ensure consistent research-grade material suitable for controlled scientific investigations.

When You Choose Grail Formula

When selecting Grail Formula, researchers receive independently verified research compounds supported by detailed Certificates of Analysis and transparent batch-specific laboratory testing.

Our quality programme includes assay verification, purity confirmation, FTIR spectrum identification, retention time analysis, molecular ion mass identification, endotoxin screening, microbiological analysis and elemental impurity testing.

Every batch is accompanied by a downloadable COA issued by Liquilabs s.r.o. Czechia, providing complete traceability and independent laboratory verification.

Research Use Limitation

• Used solely for laboratory and in vitro research
• Not approved for human consumption
• Not approved for veterinary use
• Not intended for diagnostic purposes
• Not intended for therapeutic applications
• Not permitted for clinical administration
• For research use only

• Independently analysed by Liquilabs s.r.o. Czechia
• 99.8 % purity confirmed by COA
• Assay content verified at 19.1 mg
• Identification confirmed by FTIR spectrum and retention time analysis
• Molecular ion mass identified at 461 Da
• Endotoxin level below 0.001 EU/mg
• No detectable heavy metals or microbial contamination
• Research-grade peptide compound
• For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.